G. Walldius

Publications172
h-index41
Citations8,313
Highly Influential Citations232
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • I. Jungner
  • 120 Publications, 6,391 Citations
  • N. Hammar
  • 295 Publications, 9,997 Citations
  • M. van Hemelrijck
  • 211 Publications, 3,977 Citations
  • H. Garmo
  • 326 Publications, 9,567 Citations
  • Publications
  • Influence
Apolipoprotein B and apolipoprotein A‐I: risk indicators of coronary heart disease and targets for lipid‐modifying therapy
Although LDL cholesterol (LDL‐C) is associated with an increased risk of coronary heart disease, other lipoproteins and their constituents, apolipoproteins, may play an important role in… Expand
  • 359
  • 27
The apoB/apoA‐I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid‐lowering therapy – a review of the evidence
During the last several years interest has focused on the importance of the lipid‐transporting apolipoproteins – apoB transports all potentially atherogenic very low‐density lipoprotein (VLDL),… Expand
  • 480
  • 26
PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
Measurements of haemostatic function and metabolic and angiographic indices of risk were included in a prospective cohort study of variables predictive of recurrences within 3 years in 109 unselected… Expand
  • 1,514
  • 19
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel
There is abundant evidence that the risk of atherosclerotic vascular disease is directly related to plasma cholesterol levels. Accordingly, all of the national and transnational screening and… Expand
  • 435
  • 17
Lipid Profiles and Risk of Breast and Ovarian Cancer in the Swedish AMORIS Study
Background: Obesity is a risk factor for breast and ovarian cancer; the mechanisms of action are not completely understood. Perturbed lipid metabolism often accompanies obesity; we therefore… Expand
  • 59
  • 9
  • PDF
Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment
More Nobel prizes have been awarded for the study of cholesterol than for any other molecule. Presently, concentration of LDL cholesterol is the fundamental index of risk of vascular disease. It is… Expand
  • 332
  • 8
The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk
Abstract Background: The apolipoprotein B (apoB)/apoA-I ratio represents the balance of proatherogenic and antiatherogenic lipoproteins. The purpose of this study was to determine whether the… Expand
  • 251
  • 8
Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417 734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Objectives.  Few studies have simultaneously analysed the influence of elevated serum uric acid (UA) on acute myocardial infarction (AMI), ischaemic and haemorrhagic stroke (IS, HS) and congestive… Expand
  • 184
  • 7
Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment
  • 136
  • 7
Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer
BackgroundEpidemiological evidence indicates that individuals with type 2 diabetes are at an increased risk of cancer. Elevated glucose levels, below the diagnostic threshold for diabetes, have also… Expand
  • 72
  • 7